CLOUGH CAPITAL PARTNERS L P 13D and 13G filings for Checkmate Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 10:16 am Sale | 2021-12-31 | 13G | Checkmate Pharmaceuticals, Inc. CMPI | CLOUGH CAPITAL PARTNERS L P | 1,137,764 5.260% | -414,562 (-26.71%) | Filing |
| 2021-05-24 4:03 pm Purchase | 2021-05-07 | 13G | Checkmate Pharmaceuticals, Inc. CMPI | CLOUGH CAPITAL PARTNERS L P | 1,552,326 7.180% | 201,108 (+14.88%) | Filing |
| 2021-02-12 12:22 pm Purchase | 2020-12-31 | 13G | Checkmate Pharmaceuticals, Inc. CMPI | CLOUGH CAPITAL PARTNERS L P | 1,351,218 6.270% | 18,821 (+1.41%) | Filing |
| 2020-11-10 2:54 pm Purchase | 2020-11-09 | 13G | Checkmate Pharmaceuticals, Inc. CMPI | CLOUGH CAPITAL PARTNERS L P | 1,332,397 6.220% | 1,332,397 (New Position) | Filing |